Sun Pharma sees single-digit decline in revenues for FY18 – Economic Times


Economic Times
Sun Pharma sees single-digit decline in revenues for FY18
Economic Times
“Increased competitive intensity and customer consolidation is leading to pressure on pricing; while the continued delay in approvals from the Halol facility is also impacting the company’s working,” Sun Pharmaceutical Managing Director Dilip Shanghvi

and moreĀ >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd